The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
The article presents the results of domestic and international studies of the use of the fourth-generation fluoroquinolone moxifloxacin in the treatment of commu-nity-acquired pneumonia and pneumonia caused by SARS-CoV-2. Analysis of the clinical use of moxifloxacin in the treatment of complications...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Interdisciplinary Academy of Pain Medicine
2021-11-01
|
| Series: | Perioperative Medicine |
| Subjects: | |
| Online Access: | https://perioperative.org.ua/index.php/prtmdc/article/view/78 |